These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 27738874

  • 1. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A, Molinuevo JL, Altirriba J, Sánchez-Valle R, Alcolea D, Fortea J, Rami L, Balasa M, Muñoz-García C, Ezquerra M, Fernández-Santiago R, Lleó A, Lladó A, Antonell A.
    Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
    Müller M, Jäkel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM.
    Mol Neurobiol; 2016 Jul; 53(5):2894-2899. PubMed ID: 25895659
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H.
    PLoS One; 2015 Jul; 10(5):e0126423. PubMed ID: 25992776
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017 Jul; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
    McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA, Boxer AL, Karydas A, Miller B, Robertson J, Tartaglia MC.
    Mol Neurobiol; 2018 Dec; 55(12):8826-8841. PubMed ID: 29603092
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M, Kuiperij HB, Claassen JA, Küsters B, Verbeek MM.
    Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid.
    Denk J, Jahn H.
    Methods Mol Biol; 2018 Jan; 1750():93-107. PubMed ID: 29512067
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma.
    Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, Leverenz JB.
    Biomarkers; 2013 Aug; 18(5):455-66. PubMed ID: 23822153
    [Abstract] [Full Text] [Related]

  • 14. microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.
    Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U.
    Ageing Res Rev; 2019 Jan; 49():125-143. PubMed ID: 30391753
    [Abstract] [Full Text] [Related]

  • 15. Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.
    Müller M, Kuiperij HB, Versleijen AA, Chiasserini D, Farotti L, Baschieri F, Parnetti L, Struyfs H, De Roeck N, Luyckx J, Engelborghs S, Claassen JA, Verbeek MM.
    J Alzheimers Dis; 2016 Apr 16; 52(4):1321-33. PubMed ID: 27104900
    [Abstract] [Full Text] [Related]

  • 16. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 17. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
    Swarbrick S, Wragg N, Ghosh S, Stolzing A.
    Mol Neurobiol; 2019 Sep 10; 56(9):6156-6167. PubMed ID: 30734227
    [Abstract] [Full Text] [Related]

  • 18. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.
    Mol Neurobiol; 2017 Sep 10; 54(7):5550-5562. PubMed ID: 27631879
    [Abstract] [Full Text] [Related]

  • 19. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, Wang YL, Sun L, Jiang T, Tan L.
    J Neurol Sci; 2014 Jan 15; 336(1-2):52-6. PubMed ID: 24139697
    [Abstract] [Full Text] [Related]

  • 20. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S, Reddy PH.
    Biochim Biophys Acta; 2016 Sep 15; 1862(9):1617-27. PubMed ID: 27264337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.